Skip to main content
Clinical Trials/ACTRN12615000368538
ACTRN12615000368538
Completed
Phase 2

A randomised crossover trial including clinically stable asthmatic adults to examine the effect of pre/probiotic supplements on short chain fatty acids (SCFA), airway inflammation and to study the mechanisms by which fibre exerts these effects.

A/Prof Lisa Wood0 sites17 target enrollmentApril 22, 2015

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Asthma
Sponsor
A/Prof Lisa Wood
Enrollment
17
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2015
End Date
February 26, 2016
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof Lisa Wood

Eligibility Criteria

Inclusion Criteria

  • Doctor diagnosed stable asthma
  • Aged 18\+ years
  • Males and Females
  • Never or ex\-smokers (6 months minimum cessation)

Exclusion Criteria

  • Smoking, pregnant/breastfeeding, Asthma is not the primary respiratory diagnosis, Asthma exacerbation or respiratory tract infection (oral corticosteroids or antibiotics) in the past month, Any use of antibiotics in the past month, unable or unwilling to modify diet, diagnosed bowel disorders or intestinal disorders, dietary or nutritional supplement use within the previous 4 weeks, current use of any oral medication known to significantly influence inflammation (eg statins or NSAIDs). Subject has a clinically important medical illness (including serious psychological disorders) likely to interfere with management or participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials